Literature DB >> 7671923

Late prosthetic valve endocarditis.

D Horstkotte1, C Piper, R Niehues, M Wiemer, H P Schultheiss.   

Abstract

Prosthetic valve endocarditis remains an extremely serious complication, with a low but increasing incidence. 'Late' endocarditis, occurring more than 60 days after surgery, is relatively infrequently associated with staphylococci, Gram-negative bacteria and fungi so characteristic of the endocarditis that occurs earlier. A probable source of infection can be found in 25%-80% of patients, the most frequent causes being dental procedures, urological infections and interventions, and indwelling catheters. The most common organisms are S. epidermidis, S. aureus, viridans streptococci and enterococci. The general principles of antibiotic treatment are similar to those for native valve endocarditis, but antibiotic treatment needs to be more prolonged and dosages should be used which result in maximal, nontoxic concentrations. Oral anticoagulants should be stopped and replaced by intravenous heparins. Surgical reintervention is called for if there are large highly mobile vegetations in the mitral position or within 72 h if there are cerebral thrombo-embolic episodes.

Entities:  

Mesh:

Year:  1995        PMID: 7671923     DOI: 10.1093/eurheartj/16.suppl_b.39

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Prosthetic valve endocarditis.

Authors:  C Piper; R Körfer; D Horstkotte
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 2.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

3.  Intracardiac device and prosthetic infections: What do we know?

Authors:  Lynn B Johnston; John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

Review 4.  [Modern aspects in the management of acquired heart valve lesions].

Authors:  D Horstkotte; H P Schultheiss
Journal:  Herz       Date:  1998-11       Impact factor: 1.443

5.  Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study.

Authors:  J C Castillo; M P Anguita; A Ramírez; J R Siles; F Torres; D Mesa; M Franco; I Muñoz; M Concha; F Vallés
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

6.  Management of prosthetic heart valve complications.

Authors:  Sunil Mankad
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.